Evidence map›Paper›PMID 35300578›Full record

ArticleVirulence2022

AP-1 signaling pathway promotes pro-IL-1β transcription to facilitate NLRP3 inflammasome activation upon influenza A virus infection.

Pin Wan, Simeng Zhang, Zhihui Ruan, Xueli Liu, Ge Yang, Yaling Jia, Yongkui Li, Pan Pan, Wenbiao Wang, Geng Li and 5 more

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. CD63Frontiers in cellular and infection microbiology · 2026
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Pin WanFoshan Institute of Medical Microbiology, Foshan, China.ORCID 0000-0001-5374-2356
Simeng ZhangGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
Zhihui RuanFoshan Institute of Medical Microbiology, Foshan, China.
Xueli LiuState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.
Ge YangFoshan Institute of Medical Microbiology, Foshan, China.
Yaling JiaGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
Yongkui LiFoshan Institute of Medical Microbiology, Foshan, China.
Pan PanThe First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Wenbiao WangGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
Geng LiFoshan Institute of Medical Microbiology, Foshan, China.
Xulin ChenFoshan Institute of Medical Microbiology, Foshan, China.
Zhixin LiuDepartment of Infectious Diseases, Department of Respiratory, Renmin Hospital, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China.
Qiwei ZhangFoshan Institute of Medical Microbiology, Foshan, China.ORCID 0000-0001-5952-080X
Zhen LuoFoshan Institute of Medical Microbiology, Foshan, China.ORCID 0000-0002-1142-2845
Jianguo WuFoshan Institute of Medical Microbiology, Foshan, China.ORCID 0000-0002-8326-2895
Jinan University · CNFirst Affiliated Hospital of Jinan University · CNHubei University of Medicine · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NLRP3 inflammasome mainly controls interleukin-1β (IL-1β) secretion, leading to cell death called pyroptosis constituting a major antiviral host defense and inflammatory diseases upon viral infection. The RAF-MEK1/2-ERK1/2 cascade and downstream c-Jun/Fos and Activator protein-1 (AP1) signaling pathway control the degree of inflammatory response. Influenza A virus (IAV) infection is known to stimulate NLRP3 inflammasome activation and inflammatory responses. Nevertheless, the detailed mechanism by which IAV induces NLRP3 inflammasome activation involved in transcription of pro-IL-1β mRNA remains elusive. In our study, we found that IAV infection promotes pro-IL-1β mRNA transcription and activates NLRP3 inflammasome. Detailed studies reveal that type I interferon (IFN-α/IFN-β) as well as U0126 (a selective inhibitor of MEK-1 and MEK-2) typically inhibit IAV-mediated NLRP3 inflammasome activation via downregulating pro-IL-1β mRNA. Moreover, knock-down of c-Jun decreases pro-IL-1β mRNA and inhibits NLRP3 inflammasome activation upon IAV infection. Overall, the findings uncover that AP-1 signaling pathway promotes NLRP3 inflammasome activation upon IAV infection, which provides a new idea for the therapy of NLRP3 inflammasome-associated inflammatory diseases.

Indexed as

Influenza A virusInfluenza, HumanHumansInflammasomesInterferon-betaInterleukin-1betaMitogen-Activated Protein Kinase KinasesNLR Family, Pyrin Domain-Containing 3 ProteinRNA, MessengerSignal TransductionTranscription Factor AP-1IL1B protein, humanInflammasomesInterferon-betaInterleukin-1betaMitogen-Activated Protein Kinase KinasesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanRNA, MessengerTranscription Factor AP-1AP-1 signaling pathwayinfluenza A virus, IAVinterleukin-1β, IL-1βNLRP3 inflammasometype I interferon

Identifiers

PMID35300578
PMCPMC8942419
OpenAlexW4220654676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.